
Product Name: JUN 55X Double Filtration Plasmapheresis (DFPP)
Clinical Execution: Led by Director Liu Yimei’s expert team at Boao Lecheng
Treatment Duration: 2 to 3 hours per session
Purification Capacity: Filters over 80% of total body blood with more than 2 full cycles of circulation
Price: $1,3800
Product Overview
The JUN 55X represents the pinnacle of Japanese medical engineering, serving as a leading device in international ICUs for over 30 years. Now in its sixth generation, this mature and stable system offers high-precision blood purification for patients ranging from neonates to adults. By utilizing advanced double filtration, the therapy targetically removes pathogenic substances and metabolic waste while preserving essential blood components like cells and proteins.
Therapeutic Benefits
- Vascular & Heart Protection: Filters harmful substances to reduce blood lipids and lower cardiovascular risks.
- Cellular Repair & Immunity: Repairs basic cellular structures and boosts the immune system by reducing free radical damage.
- Organ Detoxification: Repairs damaged liver cells, clears toxins from the lungs, and promotes the discharge of heavy metals.
- Vitality & Recovery: Increases blood oxygen levels to combat fatigue and improves symptoms like cold extremities or numbness.
- Functional Improvement: Enhances male sexual function and overall physical performance.
Ideal Candidates
- Chronic Health Risks: Individuals with “Three Highs” (High blood pressure, blood lipids, or blood sugar) or high heavy metal levels.
- Sub-Health & Fatigue: Those who often feel exhausted, lack energy, or have irregular sleep and diet patterns.
- Environmental & Lifestyle Exposure: Regular smokers, heavy drinkers, or those exposed to high levels of smog and pollution.
- Long-term Medication Users: Individuals frequently taking oral contraceptives, sleep aids, or weight loss medications.
- Dermatological Concerns: People with dull skin, acne, unexplained rashes, or pigmentation issues.
Pre-DFPP Clinical Assessment Package
Examination Overview Before undergoing the JUN 55X DFPP therapy, a comprehensive health screening is required to assess the patient’s baseline cardiovascular health, blood rheology, and metabolic status. This ensures the filtration parameters are perfectly calibrated to the individual’s needs.
1. Vital Signs & Physical Examination
- Physical Exam: General assessment of height, weight, blood pressure, and heart rate.
- Clinical History: Review of past medical conditions and current medication use.
2. Comprehensive Blood Analysis
- Complete Blood Count (CBC): Evaluation of red blood cells, white blood cells, and platelets.
- Blood Rheology (Viscosity): Critical assessment of blood thickness and flow characteristics to determine filtration needs.
- Coagulation Function: Testing Prothrombin Time (PT) and APTT to ensure safe anticoagulation during the 2–3 hour circulation.
3. Metabolic & Organ Function Panel
- Liver Function Test (LFT): Monitoring ALT, AST, and Bilirubin levels.
- Renal Function Test (RFT): Assessing Creatinine and Urea Nitrogen (BUN).
- Comprehensive Lipid Profile: Measuring Total Cholesterol, Triglycerides, LDL-C, and HDL-C (Targeted substances for removal).
- Glucose & Uric Acid: Testing for diabetes indicators and gout-related markers.
4. Infectious Disease Screening
- Hepatitis Panel: Screening for Hepatitis B (HBsAg) and Hepatitis C (HCV).
- HIV & Syphilis: Standard safety screening for extracorporeal blood circulation.
5. Cardiovascular & Imaging Diagnostics
- Standard 12-Lead ECG: Assessing heart rhythm and electrical activity before treatment.
- Chest X-Ray / CT (Optional): Evaluating lung health, especially for patients with a history of smoking or environmental exposure.


